Comparing Standard and Ultrasound-Accelerated Thrombolysis for Thromboembolic Disease
Author Information
Author(s): Schrijver A Marjolein, Reijnen Michel MPJ, van Oostayen Jacques A, Nolthenius Rudolf PJ Tutein, van der Valk Pieter HM, Hoksbergen Arjan WJ, Lely Rutger J, Fioole Bram, Vroegindeweij Dammis, van Leersum Marc, de Vries Jean-Paul PM
Primary Institution: St. Antonius Hospital Nieuwegein
Hypothesis
US-accelerated thrombolysis will result in a significant reduction in thrombolysis time (12 hours or more), without increasing the complication rate.
Conclusion
The DUET study aims to determine if US-accelerated thrombolysis can significantly reduce therapy time compared to standard thrombolysis without increasing complications.
Supporting Evidence
- Thrombolytic therapy has increased over the years but is limited by bleeding complications.
- Low-intensity ultrasound can accelerate thrombolysis and reduce therapy time.
- Previous studies showed high technical success rates with ultrasound-accelerated thrombolysis.
Takeaway
This study is trying to find out if a new way of breaking up blood clots can work faster and safer than the old way.
Methodology
A multicenter, 2-group parallel randomized trial involving 60 adult patients with recently thrombosed infrainguinal arteries or bypass grafts.
Limitations
The study excludes patients with certain types of artery thrombosis and those with acute limb ischemia class IIb and III.
Participant Demographics
Adults aged 18 to 85 with acute lower limb ischemia due to thrombosed infrainguinal arteries or bypass grafts.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website